A Phase 2 Study of ZEN-3694 (ZEN), Enzalutamide (ENZ), and Pembrolizumab (P) in Metastatic Castration Resistant Prostate Cancer (mCRPC): Interim Safety Results
Enzalutamide;Pembrolizumab;ZEN-3694
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 2 Study of ZEN-3694 (ZEN), Enzalutamide (ENZ), and Pembrolizumab (P) in Metastatic Castration Resistant Prostate Cancer (mCRPC): Interim Safety Results ### Output: Enzalutamide;Pembrolizumab;ZEN-3694